2011National Medical Frontiers of ChinaRequires access

A study of risperidone in the treatment of first-oneset schizophrenia

Ling Xian-chua

Open publisher page 0 citations

Abstract

Objective To compare the efficacy and safety between risperidone and clozapine.Methods Thirty schizophrenic patients were treated with risperidone and another thiety patient treated with clozapine.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the side effects were determined by the treatment emergent symptom scale(TESS).Result The efficacy rate of risperidone was 86.7%,in which 76.7% were improved markedly.The efficacy rate ot clozapine was 80.1%,in which 66.7% were improved markedly.The PANSS scores in both groups decreased significantly after treatment,risperidone has less side effects than clozapine.Conclusion Risperidone is of good efficacy,high safety and less side effects in treating schizophrenia,and patients had better compliance.

About this research paper

What this paper is about

Objective To compare the efficacy and safety between risperidone and clozapine.Methods Thirty schizophrenic patients were treated with risperidone and another thiety patient treated with clozapine.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the side effects were determined by the treatment emergent symptom scale(TESS).Result The efficacy rate of risperidone was 86.7%,in which 76.7% were improved markedly.The efficacy rate ot clozapine was 80.1%,in which 66.7% were improved markedly.The PANSS scores in both groups decreased significantly after treatment,risperidone has less side effects than clozapine.Conclusion Risperidone is of good efficacy,high safety and less side effects in treating schizophrenia,and patients had better compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy and safety between risperidone and clozapine.Methods Thirty schizophrenic patients were treated with risperidone and another thiety patient treated with clozapine.The efficacy was measured with the positive and negative symptoms scale(PANSS),while the side effects were determined by the treatment emergent symptom scale(TESS).Result The efficacy rate of risperidone was 86.7%,in which 76.7% were improved markedly.The efficacy rate ot clozapine was 80.1%,in which 66.7% were improved markedly.The PANSS scores in both groups decreased significantly after treatment,risperidone has less side effects than clozapine.Conclusion Risperidone is of good efficacy,high safety and less side effects in treating schizophrenia,and patients had better compliance.

Key concepts: Risperidone, Clozapine, Schizophrenia (object-oriented programming), Medicine, Side effect (computer science), Internal medicine, Negative symptom, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
A study of risperidone in the treatment of first-oneset schizophrenia — Research Paper | ScholarLens